» Articles » PMID: 19997800

Effect of Thrombopoietin on Platelet Counts and Liver Regeneration After Partial Hepatectomy in a Rat Model

Overview
Journal Surg Today
Specialty General Surgery
Date 2009 Dec 10
PMID 19997800
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We investigated the effects of thrombopoietin (TPO) on platelet counts and liver regeneration after partial hepatectomy in rats.

Methods: We performed 70% partial hepatectomy on 60 rats given either TPO or a vehicle (controls). The rats were killed 6 h, 24 h, 72 h, or 168 h after the procedure, and we examined the platelet counts, weight of the regenerated liver, hepatocyte proliferation by bromodeoxyuridine (BrdU) labeling index, and expression of hepatocyte growth factor (HGF) mRNA by reverse transcription-polymerase chain reaction.

Results: In the controls, the platelet counts were significantly lower than the basal levels, by about 20%, at 6, 24, and 72 h; then recovered to the basal level at 168 h. Conversely, in the TPO-treated rats, the platelet counts increased significantly by 17%, 35%, and 60%, at 24, 72, and 168 h, respectively. The regenerated liver regained 80% of the pre-hepatectomy weight by 72 h in the controls, whereas reconstitution of the liver was accomplished by 72 h in the TPO-treated rats. Thrombopoietin significantly enhanced the BrdU labeling index of hepatocytes and expression of HGF mRNA 24 h post hepatectomy in TPO-treated rats versus controls.

Conclusion: Thrombopoietin increased platelet counts; thereby accelerating liver regeneration after partial hepatectomy with enhanced induction of HGF.

Citing Articles

Role of the Hippo pathway in liver regeneration and repair: recent advances.

Pibiri M, Simbula G Inflamm Regen. 2022; 42(1):59.

PMID: 36471376 PMC: 9720992. DOI: 10.1186/s41232-022-00235-5.


Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases.

Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A Int J Mol Sci. 2021; 22(6).

PMID: 33803718 PMC: 8003150. DOI: 10.3390/ijms22063113.


Platelets in chronic liver disease, from bench to bedside.

Ramadori P, Klag T, Malek N, Heikenwalder M JHEP Rep. 2020; 1(6):448-459.

PMID: 32039397 PMC: 7005648. DOI: 10.1016/j.jhepr.2019.10.001.


Platelets and Platelet-Derived Extracellular Vesicles in Liver Physiology and Disease.

Balaphas A, Meyer J, Sadoul K, Fontana P, Morel P, Gonelle-Gispert C Hepatol Commun. 2019; 3(7):855-866.

PMID: 31304449 PMC: 6601322. DOI: 10.1002/hep4.1358.


Evidence against a role for platelet-derived molecules in liver regeneration after partial hepatectomy in humans.

Kirschbaum M, Adelmeijer J, Alkozai E, Porte R, Lisman T J Clin Transl Res. 2019; 2(3):97-106.

PMID: 30873468 PMC: 6410653.


References
1.
Shimada Y, Kato T, Ogami K, Horie K, Kokubo A, Kudo Y . Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol. 1995; 23(13):1388-96. View

2.
Napoli J, Prentice D, Niinami C, Bishop G, Desmond P, McCaughan G . Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology. 1997; 26(3):624-33. DOI: 10.1002/hep.510260314. View

3.
Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L . Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis. 2002; 4(1):37-43. DOI: 10.1023/a:1016611230747. View

4.
Kaushansky K, Broudy V, Lin N, Jorgensen M, McCarty J, Fox N . Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A. 1995; 92(8):3234-8. PMC: 42140. DOI: 10.1073/pnas.92.8.3234. View

5.
de Sauvage F, Hass P, Spencer S, Malloy B, Gurney A, Spencer S . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369(6481):533-8. DOI: 10.1038/369533a0. View